MSF is collaborating with health authorities and academic partners in the Arkhangelsk and Vladimir regions to reduce the burden of drug-resistant tuberculosis.
Our teams are working on a study in collaboration with the Ministry of Health, which aims to prove the effectiveness of all-oral novel short-course regimens for patients with DR-TB. In 2021, more than 60 people were enrolled into the study in the regions of Arkhangelsk and Vladimir. By the end of 2021, the first patients completed their treatment and started the follow-up stage.
In Moscow and St. Petersburg, we continue our partnership with two community-based NGOs, offering healthcare to vulnerable people, including those living with HIV. The current project has been running since 2020, and has expanded its support from COVID-19 to additional infectious diseases.
Since the war in Ukraine escalated in 2022, many people have sought safety in Russia. We have set up teams in Russia to explore the humanitarian and medical needs of refugees and displaced people.
In Russia, Médecins Sans Frontières provides treatment for people with drug-resistant tuberculosis (DR-TB) and HIV. We also responded to the needs of people displaced by the conflict in Ukraine.
